Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - ergometrinijev maleat - filmsko obložena tableta - ergometrinijev maleat 200 µg / 1 tableta - ergometrin

Evropska unija - slovenščina - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - druga zdravila na živčnem sistemu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Evropska unija - slovenščina - EMA (European Medicines Agency)

molmed spa - alogenskih t celice, gensko spremenjene z retrovirusni vektor kodiranje za skrajšani obliki ljudi nizko afiniteto živca rastni faktor receptor (Δlngfr) in herpes simplex virus timidin-kinazo (hsv-tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - antineoplastična sredstva - zalmoxis je indiciran kot dodatno zdravljenje pri haploidentični hematopoetski presaditvi matičnih celic (hsct) pri odraslih bolnikih z visokim tveganjem hematoloških malignomov.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mcneil ab - nikotin - transdermalni obliž - nikotin 39,37 mg / 1 obliž - nikotin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mcneil ab - nikotin - transdermalni obliž - nikotin 23,62 mg / 1 obliž - nikotin

Evropska unija - slovenščina - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitizinon - tyrosinemias - drugi zdravljene bolezni prebavil in presnove izdelki, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Evropska unija - slovenščina - EMA (European Medicines Agency)

mendelikabs europe ltd - nitizinon - tyrosinemias - drugi zdravljene bolezni prebavil in presnove izdelki, - zdravljenje odraslih in pediatričnih bolnikov s katero je bila potrjena diagnoza dedne tipografije tipa 1 (ht 1) v kombinaciji s prehransko omejitvijo tirozina in fenilalanina.

Evropska unija - slovenščina - EMA (European Medicines Agency)

cycle pharmaceuticals (europe) ltd - nitizinon - tyrosinemias - drugi zdravljene bolezni prebavil in presnove izdelki, - za zdravljenje odraslih in pediatričnih bolnikih s potrjeno diagnozo dedno tyrosinemia tip 1 (ht-1) v kombinaciji z prehranskih omejitev tirozin in fenilalanin.

Evropska unija - slovenščina - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 in 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

b. braun melsungen ag - izopropilalkohol; povidon, jodirani - dermalna raztopina - izopropilalkohol 500 mg / 1 g  povidon, jodirani10 mg / 1 g; povidon, jodirani 10 mg / 1 g - povidon-jod